口服对比增强经腹超声与增强CT对胃癌术前分期的前瞻性比较
前瞻性纳入108例胃癌患者,同时行口服对比增强经腹超声(OCTU)与增强CT术前T分期,以术后病理为金标准(AJCC第8版)。OCTU与增强CT总体分期准确率无统计学差异(72.2% vs 75.9%,p=0.644)。各T分期准确率OCTU在T1较高(84.2%),增强CT在T3较高(87.8%)。
要点
- OCTU与增强CT对胃癌术前总体T分期诊断准确率相当,无统计学差异。
- OCTU对T1期准确率较高(84.2%),增强CT对T3期准确率较高(87.8%)。
- 阅片时可结合两种方法互补优势,尤其关注T1与T3分期。
英文原文(摘要)· 点击展开
The aim of this prospective study was to compare the diagnostic accuracy of oral contrast-enhanced transabdominal ultrasound imaging (OCTU) with that of contrast-enhanced computed tomography (CT) for the pre-operative tumor staging of gastric cancer, with post-operative pathology as the standard. We included 108 cases of gastric cancer with simultaneous OCTU and enhanced CT pre-operative tumor staging diagnoses. Results were compared with post-operative pathology based on the eighth edition of the American Joint Committee on Cancer tumor-node-metastasis staging guidelines for gastric cancer. The accuracy of each tumor stage was obtained by comparing OCTU and enhanced CT diagnoses with post-operative pathology. The McNemar test was used to compare the overall accuracy of the two methods. There was no statistical difference in accuracy between OCTU (72.2%) and enhanced CT (75.9%, p = 0.644) for overall pre-operative tumor staging diagnosis. For stages T1 to T4, the accuracy rates of OCTU were 84.2%, 81.8%, 69.4% and 65.5%, respectively, and those for enhanced CT were 52.6%, 72.7%, 87.8% and 72.4%, respectively. OCTU is comparable to enhanced CT in the preoperative overall T-stage diagnosis of gastric cancer.
引用
- Wu, Xin, Wang, et al. Prospective Comparison of Oral Contrast-Enhanced Transabdominal Ultrasound Imaging With Contrast-Enhanced Computed Tomography in Pre-operative Tumor Staging of Gastric Cancer. Ultrasound Med Biol. 2022. PMID: 36369213. doi:10.1016/j.ultrasmedbio.2022.10.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。